Home › Pulmonary Hypertension › Minnesota › Rochester
Pulmonary Hypertension clinical trials in Rochester, MN
7 studies for Pulmonary Hypertension are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Mayo Clinic - Rochester, Rochester
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- Mayo Clinic, Rochester
Real World Observational Study of Sotatercept for Pulmonary Hypertension
RecruitingObservational study
- Mayo Clinic, Rochester
Pulmonary Hypertension in Left Heart Disease
RecruitingObservational study
- Mayo Clinic in Rochester, Rochester
CVD/PH and Voice Characteristics
RecruitingObservational study
- Mayo Clinic, Rochester
Pulmonary Hypertension Association Registry
RecruitingObservational study
- Mayo Clinic, Rochester
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Recruiting
- Mayo Clinic, Rochester
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Phoenix, AZ9 studies
- Aurora, CO9 studies
- Kansas City, KS8 studies
- Cincinnati, OH8 studies
- New York City, NY8 studies
- Boston, MA8 studies
- Indianapolis, IN8 studies
- Salt Lake City, UT7 studies
- Bend, OR7 studies
- Houston, TX7 studies
- Charleston, SC7 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Multiple Myeloma24 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Pancreatic Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.